This site is intended for Healthcare Professionals only.

Tag: Medicines and Healthcare products Regulatory Agency

UK approves CStone’s Sugemalimab for non-small cell lung cancer treatment

Patients treated with sugemalimab lived on average 9.0 months without disease progression, compared to 4.9 months in the placebo group The Medicines and Healthcare products...

Report misuse of weight-loss drugs: MHRA urges healthcare professionals

Weight-loss drugs like Wegovy and Mounjaro may sometimes lead to serious complications, resulting in hospitalisation  “Weight-loss drugs are not a quick fix for losing a...

MHRA uses fast-track process to approve first medicine for rare immune disease APDS

The Medicines and Healthcare products Regulatory Agency (MHRA) has on Friday approved leniolisib phosphate (Joenja) to treat a rare immune disease known as activated...

MHRA review finds no evidence linking GLP-1 receptor agonists to suicidal thoughts

GLP-1 receptor agonists are used to treat type 2 diabetes and obesity Following a comprehensive review, the Medicines and Healthcare products Regulatory Agency (MHRA) has...

New drug approved for Alzheimer’s disease may not be available to NHS patients?

Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain The Medicines and Healthcare products Regulatory Agency (MHRA) has approved...

5 summer tips from MHRA for managing medications and devices

The Medicines and Healthcare products Regulatory Agency (MHRA) has shared some important summer tips for people taking medicines or using medical devices People are advised...